Archive January 3, 2017 Deciphera Pharmaceuticals to Present at 35th Annual J.P. Morgan Healthcare Conference
Archive December 1, 2016 Deciphera Pharmaceuticals Reports Encouraging Clinical Results with DCC-2618 in Genetically-defined Cancers with Drug Resistant Mutations
Archive October 31, 2016 Deciphera Pharmaceuticals to Present Clinical Data on Tumor Targeted Advanced Kinase Inhibitors at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Archive October 6, 2016 Deciphera Pharmaceuticals Appoints Christopher J. Morl, M.B.A. as Chief Business Officer
Archive October 6, 2016 Deciphera Pharmaceuticals Expands Board with Appointment of Two New Directors
Archive August 1, 2016 Deciphera Pharmaceuticals to Present at the Canaccord Genuity 36th Annual Growth Conference
Archive June 16, 2016 Deciphera Pharmaceuticals to Present at JMP Securities Life Sciences Conference
Archive April 20, 2016 Deciphera’s Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, Demonstrates Potent Macrophage Checkpoint Inhibition as a Single Agent and In Combination with an Anti-PD1 Inhibitor
Archive March 21, 2016 Deciphera Pharmaceuticals Announces Study Results for Altiratinib Demonstrating Inhibition of Tumor Growth and Invasiveness in Glioblastoma
